Funding

DeepCyte

United States · Biotech · Healthtech · AI · Enterprise software

Builds AI toxicology tools for drug development

Visit deepcyte.bioFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Seed$1.5MCarl J. G. Evertsz — Role not disclosed

Investors

Carl J. G. EvertszSeed

Coverage

Apr 9, 2026DeepCyte · Seed

Similar companies

Fairy DevicesTokyo company developing wearable devices and remote-assistance software for industrial field workers.Undisclosed · JICN equity investment
Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Knowledge WorkTokyo software company developing sales AI agents, an agent operating platform and consulting services for enterprise sales teams.¥4.8B · Series C debt second close
Sourcesdeepcyte.bio ↗